Stay updated on Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Sign up to get notified when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.

Latest updates to the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page
- Check2 days agoChange DetectedThe addition 'No longer looking for participants' indicates the study is no longer seeking enrollees, clarifying enrollment status within the history. A new revision tag 'Revision: v3.6.0' appears in the history, replacing the previous 'Revision: v3.5.5'.SummaryDifference0.4%

- Check9 days agoChange DetectedThe record history now includes a new revision entry (v3.5.5) and removes the previous revision (v3.5.4) from the history, updating the version trail for the study. This reflects a log-level update rather than a change to the study data.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.5.4 was added and the previous v3.5.3 was removed in the Study Record Versions, updating the page's revision history to reflect a newer revision of the study record.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov site release without altering the displayed study record history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe 2026-04-06 update adds References, Study Status, and Study Identification to the record history, and a 2019-04-18 deletion is noted in the changes.SummaryDifference0.6%

- Check88 days agoChange DetectedNew revision v3.5.0 added and v3.4.3 removed in the study record history. This update affects only the revision list and does not modify the underlying study data.SummaryDifference0.1%

Stay in the know with updates to Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.